diabetestalk.net

Humalog Cost

Why Is Humalog Expensive? And How Can You Save?

Why Is Humalog Expensive? And How Can You Save?

Why is Humalog Expensive? And How Can You Save? Tori Marsh, MPH, is on the Research Team at GoodRx, and is the resident expert on drug pricing and savings. Humalog (insulinlispro) is a fast-acting insulin used to treat diabetes type one and two. Doctors report low levels of adherence to insulins like Humalog because of its cost. Cash prices for Humalog average around $549 for five kwikpens, and there is no generic alternative for any insulin brand. Humalog generated billions of dollars in global sales for Eli Lilly in 2016. Here is some information on Humalog, and how you can save. Typically, when a manufacturer releases a brand name drug, it is protected by a patent. This means that the manufacturer holds market exclusivity for that drug, preventing other manufacturers from creating an alternative. The idea is to incentivize companies to innovate (such as spending money researching new drugs) with a period when they can reap the rewards for their work. Eventually, though, the patent expires, allowing competitors to create their own versions with the same active ingredient. These are known as generics. In the case of Humalog, the patent expired in 2015, but no generic is on the market yet, and we may never see one. The reason has to do with the difference between drugs made of chemical formulations (think of any ordinary pill), and those treatments made from living, biologic organisms such as insulin. Humalogs biosimilar follow-on, Admelog , was approved last year but is not yet available in pharmacies. Stay tuned, we will keep you updated. Get the best ways to save on your prescriptions delivered to your inbox. By signing up, I agree to GoodRx's terms of service and privacy policy . The cash price for insulins can range anywhere from $120 to $600 a month. At the momen Continue reading >>

Why Treating Diabetes Keeps Getting More Expensive

Why Treating Diabetes Keeps Getting More Expensive

Laura Marston is one of the 1.25 million Americans who suffer from Type 1 diabetes, an autoimmune disorder in which a person's pancreas can't make insulin. She hoards vials of the life-saving medicine in her refrigerator to protect herself from the drug's rising prices. (Jorge Ribas/The Washington Post) At first, the researchers who discovered insulin agonized about whether to patent the drug at all. It was 1921, and the team of biochemists and physicians based in Toronto was troubled by the idea of profiting from a medicine that had such widespread human value, one that could transform diabetes from a death sentence into a manageable disease. Ultimately, they decided to file for a patent — and promptly sold it to the University of Toronto for $3, or $1 for each person listed. It was the best way, they believed, to ensure that no company would have a monopoly and patients would have affordable access to a safe, effective drug. “Above all, these were discoverers who were trying to do a great humanitarian thing,” said historian Michael Bliss, “and they hoped their discovery was a kind of gift to humanity.” But the drug also has become a gift to the pharmaceutical industry. A version of insulin that carried a list price of $17 a vial in 1997 is priced at $138 today. Another that launched two decades ago with a sticker price of $21 a vial has been increased to $255. [This 90-year-old fight over insulin royalties reveals just how much has changed in medicine] Seventy-five years after the original insulin patent expired — a point at which drug prices usually decline — three companies have made incremental improvements to insulin that generate new patents and profits, creating a family of modern insulins worth billions of dollars. The history of insulin captures Continue reading >>

How To Get Insulin At A Cheaper Price

How To Get Insulin At A Cheaper Price

Insulin can be expensive. If you’re one of the 6 million Americans with diabetes relying on this main-stay treatment, you could be paying out-of-pocket costs anywhere from $120 to $400 per month, according to a 2015 New England Journal of Medicine commentary. Drugs such as Lantus (insulin glargine) and Levemir (insulin detemir) have seen significant cost increases, according to a recent trend report by pharmacy benefit manager Express Scripts. One reason for the high prices is the lack of generic options for insulin. So for now, you’re stuck having to search around to find affordable options. Where do you shop for more affordable insulin? For some people though, high drug costs can mean making difficult financial choices. Our national polls show people might cut back on groceries and paying bills to pay for their medications. To minimize your costs, consider these options: Prescription Assistance Programs If you don’t have health insurance or are without drug coverage, look into applying for a patient assistance program (PAP). Through the nonprofit NeedyMeds, you can find some programs that offer free or low-cost insulin as long as you meet the eligibility requirements. Those are usually based on your insurance status, income, and diagnosis. You might also qualify for a diagnosis-specific program that can help you save on syringes, pumps, and other diabetes supplies. Pharmacists are also a great resource and can help you find a PAP that meets your financial needs. Switch Drugs Another way to save is by asking your doctor whether there’s a lower-priced insulin that’s right for you. While “long-acting” is a more popular type of insulin, it's also more expensive, but that doesn’t necessarily mean it works better. “It’s mostly a marketing ploy,” says M Continue reading >>

The Prices For Life-saving Diabetes Medications Have Increased Again

The Prices For Life-saving Diabetes Medications Have Increased Again

A Type 1 diabetes patient holds up bottles of insulin. Reuters/Lucy Nicholson Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment. It's led some people living with diabetes to turn to the black market, crowdfunding pages, and Facebook pages to get access to the life-saving drug. At the same time, the companies that make insulin have faced pressure from politicians including Senator Bernie Sanders, class-action lawsuits that accuse the companies of price-fixing, and proposed legislation in Nevada. Even in the face of this criticism, two of those drugmakers — Eli Lilly and Novo Nordisk — raised the list price of their insulins again in 2017. Diabetes is a group of conditions in which the body can't properly regulate blood sugar that affects roughly 30 million people in the US. For many people living with diabetes — including the 1.25 million people in the US who have type-1 diabetes — injecting insulin is part of the daily routine. Insulin, a hormone that healthy bodies produce, has been used to treat diabetes for almost a century, though it's gone through some modifications. As of May 2, the list price of Humalog, a short-acting insulin, is $274.70 for a 10 ml bottle, an increase of 7.8% from what the list price had been since July 2016. On May 2, Lilly also took a 7.8% list price increase to Humulin, an older form of insulin. Novo Nordisk, which also makes a short-acting insulin, increased its prices to the drug in 2017. In February, the drugmaker raised its price to $275.58 for a 10 ml bottle, up 7.9% from what the list price had been since July 2016. In December, Novo Nordisk committed to limiting all future drug list price increases from the company to single d Continue reading >>

Insulin Prices Have Skyrocketed, Putting Drug Makers On The Defensive

Insulin Prices Have Skyrocketed, Putting Drug Makers On The Defensive

Here’s a sticking point for diabetics: the cost of insulin more than tripled — from $231 to $736 a year per patient — between 2002 and 2013, according to a new analysis. The increase reflected rising prices for a milliliter of insulin, which climbed 197 percent from $4.34 per to $12.92 during the same period. Meanwhile, the amount of money spent by each patient on other diabetes medications fell 16 percent, to $502 from $600, according to a research letter published Tuesday in the Journal of the American Medical Association. “Insulin is a life-saving medication,” said Dr. William Herman, a coauthor of the analysis and a professor of medicine and epidemiology at the University of Michigan School of Public Health. “There are people with type 1 diabetes who will die without insulin. And while there have been incremental benefits in insulin products, prices have been rising. So there are people who can’t afford them. It’s a real problem.” The analysis also found that the cost of various widely used oral diabetes drugs either dropped in price or did not rise nearly as significantly as insulin. Metformin, for instance, which is available as a generic, fell to 31 cents in 2013 from $1.24 per tablet in 2002. And the newer class of diabetes drugs known as DPP-4 inhibitors rose 34 percent since becoming available in 2006. The researchers analyzed data from nearly 28,000 diabetes patients found in the Medical Expenditure Panel, a database on health care costs maintained by the US Department of Health and Human Services. About 1 in 4 people used insulin and two-thirds took a pill. Toward the end of the study period, a small percentage began taking new injectable medicines that are designed to complement pills. There have been previous efforts to track insulin pric Continue reading >>

Why Humalog® U-200 Kwikpen®?

Why Humalog® U-200 Kwikpen®?

You may have been taking a long-acting insulin for a while now. So why did your doctor prescribe another insulin? Well, it’s to help control the blood sugar spikes that happen naturally when you eat. Everyone gets them, but when you have diabetes you may need extra help controlling them. That’s where Humalog comes in. Humalog is different than your long-acting insulin. Long-acting insulin helps control your blood sugar throughout the whole day. Humalog is fast-acting insulin—it helps control the blood sugar spikes that happen naturally when you eat. Humalog is available in the Humalog U-200 KwikPen, which is portable. And, since it shouldn’t be refrigerated after the first use, you can take it just about anywhere. Continue reading >>

Buy Humalog (insulin Lispro) Vials 10 Ml 100iu/ml Online

Buy Humalog (insulin Lispro) Vials 10 Ml 100iu/ml Online

Humalog (Insulin Lispro) Vials 10 mL 100 IU/mL QTY TYPE PRICE PRICE PER UNIT 1 10ML 100IU/ML VIAL $71.63 $71.63 2 10ML 100IU/ML VIAL $111.80 $55.90 3 10ML 100IU/ML VIAL $151.98 $50.66 4 10ML 100IU/ML VIAL $192.16 $48.04 5 10ML 100IU/ML VIAL $237.35 $47.47 6 10ML 100IU/ML VIAL $279.12 $46.52 7 10ML 100IU/ML VIAL $321.44 $45.92 8 10ML 100IU/ML VIAL $362.88 $45.36 9 10ML 100IU/ML VIAL $403.38 $44.82 10 10ML 100IU/ML VIAL $444.20 $44.42 VIEW ALL INSULIN PRODUCTSPLACE A NEW INSULIN ORDER What is Humalog Insulin Lispro? Humalog is the brand name of a variety of insulin analog products that includes insulin lispro, which is a rapid-acting insulin analog solution. Rapid-acting insulin analogs are also referred to as bolus, or mealtime insulin. It is genetically engineered from a safe laboratory strain of E. coli. bacteria specifically to help control the spike in blood sugar level during and after eating. Vials contain insulin lispro for subcutaneous (under the skin) injection. It is available as Humalog (insulin lispro) in a 10 mL 100 IU/mL vial. What is it used for? Humalog insulin lispro injection is used for the treatment of adults and children living with type 1 diabetes or type 2 diabetes. It has also shown effectiveness in helping prevent diabetic nephropathy, diabetic neuropathy, and cardiovascular disease, although it has not been officially approved for the prevention of any of these conditions. It is indicated for the treatment of those people who need insulin for maintenance of blood sugar levels and also for the initial stabilization of diabetes mellitus. It is short-acting, and it is meant for use together with a longer acting insulin, such as Humulin N (insulin isophane NPH), except when used in a subcutaneous (under the skin) insulin infusion pump. How does it w Continue reading >>

Rising Insulin Prices Have Diabetics Crying Foul

Rising Insulin Prices Have Diabetics Crying Foul

Insulin prices are only getting more painful. Drugmakers Eli Lilly (LLY) and Novo Nordisk recently boosted their insulin list prices by almost 8 percent each, adding to concerns that treating diabetes is unaffordable for some patients. The average price of insulin almost tripled between 2002 and 2013, according to the American Diabetes Association (ADA). Even before the most recent price hike, some diabetics were cutting back or even going without the drug because of its expense. The price hikes come at a sensitive time for the drugmakers as Eli Lilly, Novo Nordisk and rival Sanofi-Aventis are facing a class-action lawsuit alleging they conspired to raise their prices in lockstep. Almost one in 10 Americans has diabetes, a group of conditions where the body fails to properly regulate blood sugar. People with Type 1 diabetes, often referred to as juvenile diabetes, need to take insulin daily to stay alive. "We were really disappointed in this announcement," said Dr. William Cefalu, the chief scientific, medical and mission officer for the ADA, who noted that his organization has partnerships for research with the drugmakers. "This is really going in the wrong direction." In early May, Eli Lilly raised its list price for Humalog by 7.8 percent, to $274.70, for a 10-milliliter bottle, while Novo Nordisk tacked on a 7.9 percent increase on its Novolog drug, to $275.58. "There's concern and anger in the diabetes community," said Allison Bailey, who has Type 1 diabetes and is a student at Iowa State University. She also volunteers with a diabetes advocacy group called T1International. She called the most recent price hike "a slap in the face." Such price hikes may be absorbed by diabetics' insurance plans, but other people may struggle if they lack insurance or have high-dedu Continue reading >>

Soaring Insulin Prices Prompt Insurance Shift

Soaring Insulin Prices Prompt Insurance Shift

Since 2002, the cost of insulin has increased by almost 200 percent, according to a new study.Video provided by Newsy Newslook Corrections and clarifications:This story has been updated to reflect fact that Basaglar can’t be used in an insulin pump. Many parents of diabetic children and adults suffering with type 1 or type 2 diabetes are bracing for changes in insurance coverage of their insulin next year, as prices of the vital medication continue to soar. Higher insurance deductibles and changes in the prescription brands covered by some insurers are raising concerns among some people with diabetes. CVS Caremark, a pharmacy benefit manager (PBM), will no longer cover the insulin brand Lantus in favor of a new biosimilar version, Basaglar. Biosimilars are considered the generic versions of "biologic" drugs that are based on natural sources. The company also announced a program last week to further keep diabetes costs down, following a similar move in August by competitor Express Scripts. Diabetes is an epidemic in the United States, affecting nearly 10% of the population or about 29 million people, according to the Centers for Disease Control and Prevention. Of those, more than 8 million people are undiagnosed. Type 1 diabetes — often still called juvenile diabetes — can occur when people are children or adults. Type 2 diabetes is becoming more common with the increase in obesity and sedentary behavior. Prices for Humalog and many insulin brands have increased from about $300 to $500 between January 2013 to October 2016, according to drug discount search company GoodRx. Lantus increased about 60% — from $240 to $380 — in the same time period, GoodRx says. (Photo: T1D Exchange) "It’s definitely unfortunate prices are going up so much and impacting the people Continue reading >>

Humalog Vs. Novolog: Important Differences And More

Humalog Vs. Novolog: Important Differences And More

Humalog and Novolog are two diabetes medications. Humalog is the brand-name version of insulin lispro, and Novolog is the brand-name version of insulin aspart. These drugs both help control blood glucose (sugar) in people with type 1 and type 2 diabetes. Humalog and Novolog are both rapid acting. That means they work more quickly than other types of insulin. There are important distinctions between Humalog and Novolog, however, and the drugs are not directly interchangeable. Check out this comparison so you can work with your doctor to choose a drug that’s right for you. Insulin is injected under your skin fat. It’s the most common type of treatment for type 1 diabetes because it works quickly. It’s also the only type of diabetes medication that’s absorbed into the bloodstream. Humalog and Novolog are both equivalent to the insulin made in your body. Unlike oral diabetes drugs, insulin provides fast relief for changes in your blood sugar. The type of insulin your doctor prescribes depends on how often and how much your blood sugar fluctuates each day. The table below provides quick facts at a glance. Brand name Humalog Novolog What is the generic drug? insulin lispro insulin aspart Is a generic version available? no no What does it treat? type 1 and type 2 diabetes type 1 and type 2 diabetes What form does it come in? solution for injection solution for injection What strengths does it come in? • 3-mL cartridges • 3-mL prefilled KwikPen • 3-mL vials • 10-mL vials • 3-mL FlexPen • 3-mL FlexTouch • 3-mL PenFill cartridges • 10-mL vials What is the typical length of treatment? long-term long-term How do I store it? Refrigerate at 36° to 46°F (2° to 8°C). Do not freeze the drug. Refrigerate at 36° to 46°F (2° to 8°C). Do not freeze the drug. Continue reading >>

The Rising Price Of Insulin

The Rising Price Of Insulin

Diabetes is a chronic disease that afflicts 25.8 million Americans. Insulin, one of the primary treatments for diabetes, has been around since the 1920s. Yet, somehow the drug is still priced beyond the reach of many Americans. One of our advocates recently left a comment on our Facebook page regarding this problem, which encouraged us to take a closer look at it. Medication nonadherence (patients not taking medicine as prescribed) is undeniably related to diabetes-related health complications that result in emergency room visits and lost productivity. Diabetes is an expensive and deadly disease. It is the seventh leading cause of death in the U.S. and cost the country $245 billion last year. A few big pharmaceutical firms dominate the insulin market due to lengthy patents and lack of generic competition. Insulin is a biologic drug, which means that it is made up of living organisms rather than chemical compounds. This makes it more difficult to copy, which biotech companies often use as justification for the exorbitant prices they charge for the drugs. We’ve had anecdotal evidence from a consumer of a big price hike on her Humalog insulin this year. When she was trying to find out further information about the price increase, she was told by her insurance company to expect the drug to go up 25 percent more in December. News reports indicate that the cost of Lantus, a top-selling insulin produced by Sanofi, has gone up twice already this year, first 10 and then 15 percent. In addition, Novo Nordisk has also increased the price of Levemir, another common insulin treatment, by 10 percent. What’s going on here? Overall drug spending is slightly down due to generic drug utilization being up. And generic competition isn’t too far off for many of these drugs. It looks l Continue reading >>

When You Can't Afford The Insulin That You Need To Survive | How To Use The Cheap

When You Can't Afford The Insulin That You Need To Survive | How To Use The Cheap "old-school" Insulin

Note: BootCamp for Betics is not a medical center. Anything you read on this site should not be considered medical advice, and is for educational purposes only. Always consult with a physician or a diabetes nurse educator before starting or changing insulin doses. Did you know that all type 1 diabetics and some type 2 diabetics need injectable insulin in order to live? Put another way, if a diabetic needs insulin in order to live, and the diabetic does not get insulin, the diabetic will die. Diabetic death from Diabetic Ketoacidosis is a grisly process, during which acid starts running through your bloodstream, searing your vessels and organs while your body shrivels up in dehydration as it tries to push the acid out of your body through your urine and lungs, and, left untreated, the condition shuts down your organs one by one until you are dead. If you're lucky, your brain will be the first thing to swell itself into a coma and you'll be unconscious for the remainder of the organ failures. In some cases, this grisly diabetic death can take a few days or weeks to complete its process. Or, if you're one of the luckier less-resistant insulin-dependent type 2 diabetics, you may actually get away with staying alive for quite a few years and suffer only some heart disease, stroke, kidney damage/failure, neuropathy, limb amputations and blindness. (my intent in describing how lack of insulin leads to death is not to cause fear in people with diabetes or their loved ones; rather, my intent is to make clear the reality that injectable insulin is absolutely vital to diabetics who depend on injectable insulin to live) While I'd love to go off on a political rant about how insulin should be a basic human right for all insulin-dependent diabetics (and why the hell isn't it?), that' Continue reading >>

Humalog Kwikpen Price

Humalog Kwikpen Price

Humalog Kwikpen is a portable insulin device given to people who have type 2 diabetes. Containing insulin lispro, Humalog Kwikpen is manufactured by Eli Lilly and Company Limited. Other active ingredients of this medicine are glycerol, zinc oxide, m-cresol, hydrochloric acid and sodium hydroxide. Humalog Kwikpen is prescribed specifically to provide insulin for people with diabetes. Insulin is a hormone that helps the body in properly using the sugar found in the blood. It particularly helps prevent blood sugar from increasing to dangerous levels. People with diabetes don’t produce enough insulin in their bodies, and this is why insulin devices like Humalog Kwikpen are prescribed to them. The amount of insulin given to a patient will depend on the diagnosis of a physician, who may need regular measurement of the patient’s blood sugar levels. At times, the amount of Humalog may be changed depending on factors like changes to the diet, changes to the patient’s health, changes in physical activity, or use of another insulin type. Humalog Kwikpen Cost Information Humalog Kwikpen prices vary depending on the store that retails it. A carton of Humalog that contains five kwikpens can go for as low a $280 to as much as $350. However, buyers may get it at a lower price from online stores if they use discount coupons. Continue reading >>

Humalog Vs. Novolog: What’s The Difference?

Humalog Vs. Novolog: What’s The Difference?

The two leaders in the fast acting insulin market, Humalog and Novolog, are the most common types of fast acting insulin used by those with diabetes today. Fast Acting, mealtime insulin is a type of insulin that is injected before or right after eating. When you eat your blood glucose begins to rise. Fast acting insulin, Humalog and Novolog work to help manage these rises or spikes to keep your blood glucose levels more within range and balanced. When you use a fast acting insulin like Humalog or Novolog, you typically will continue to take a long acting insulin to help manage your levels between your meals and throughout the night. The question is though, is there really a difference between the two? Endocrinologists and other medical professionals don’t seem to really think there is, stating the two are virtually interchangeable. But that’s not really the full story. Humalog (Insulin Lispro) Insulin Lispro (Humalog) has been on the market since 1996, when it was first introduced by Eli Lily. Humalog is the first insulin analogue that was used clinically. Insulin Lispro received its name due to its structure. The difference between it and regular insulin was the switch between the lysine B28 (an amino acid) and proline B29. The formula consists of a hexametric solution available in vials and pen form. After a subcutaneous injection, the formula converts into a monomeric formula which allows it to have a fast absorption in the body. The one noted negative factor of Humalog is its short term control of glucose levels. Additionally, if it is injected and mealtime happens to be delayed, a hypoglycemic episode may occur. For Humalog to be most effective it is to be injected 15 minutes prior to the start of a meal. I recommend reading the following articles: Humalog is a Continue reading >>

Why Walmart Insulins Aren’t The Answer To High Insulin Prices

Why Walmart Insulins Aren’t The Answer To High Insulin Prices

A diabetes advocate contrasts the performance of generic insulins versus the more popular brands. Commentary Some people don’t understand why people with diabetes get upset at the price of insulin. They see insulin for sale at a relatively reasonable price in Walmart and don’t see the problem. What they don’t know is that these Walmart insulins just don’t perform nearly as well as the more expensive insulins, and that gap in performance can have a very negative effect on the health of people with diabetes. There are three insulins available at Walmart for the price of $25 – NPH, Regular, and 70/30 (a mix of the two). NPH was first approved by the FDA in 1950, Regular was approved in 1982, 70/30 in 1989. That means NPH has been around for 66 years, Regular for 33 years, 70/30 for 27 years. Take a moment and think about what healthcare was like in 1950. Now, I’m sure someone is saying, “Well, they must still work if they are still being sold.” And they do, but they don’t work in the same way. These insulins are not interchangeable. If a person with Type 1 diabetes were to switch from a Humalog/Lantus insulin regimen to Regular and NPH, it would drastically alter their lifestyle, making blood sugar control more irregular and raising A1C scores. The biggest issue is that whereas Lantus is steady, NPH peaks. A person using NPH must keep a very set dietary schedule, making sure to eat meals and snacks at certain times to correspond with peak times of an insulin dose. The strict schedule is difficult for everyone, but especially for children. They are unable to alter their daily schedules and must always be sure to eat at specific times. Even if they’re not hungry, they must eat to avoid low blood sugar. And if they are hungry, they often cannot have more t Continue reading >>

More in diabetes